In its second earnings call as a public company, Livongo was able to report strong financial and operational numbers and raise its revenue guidance for the year from $7 million to $9.5 million. CEO Zane Burke also shared that the company's diversification beyond diabetes is making progress: more than 20% of the company's estimated value from new partnerships is from non-diabetes business.
TOPLINE...
Fitbit’s year-over-year device sales flatlined in Q3 2019, which combined with lower sales tag prices drove a decline in revenue, according to the wearables maker’s latest quarterly earnings.
The reporting — which was bereft of an investor’s call, Q&A and any forward-looking statements due to the company’s pending acquisition — is the latest look at a wearables business Google apparently...
It may have been easy to miss, given the excitement of the quarter’s IPOs, but the third quarter of 2019 was actually a light one for digital health mergers and acquisitions, with just 10 deals — compared to 17 in Q1 and 12 in Q2.
As usual, we’ve ordered acquisitions by price first, then chronologically for the unknown terms — which is most of them. It’s worth noting that the quarter also saw...
